Stocks in Asia-Pacific were mixed on Wednesday trade as a recent rally bolstered by coronavirus vaccine hopes and reduced uncertainty in U.S. politics paused.
Analysis by Citi Research showed that the economic benefits of vaccination may not kick in until late 2021, when "herd immunity" is expected to start forming.
The best pockets of recovery are domestic travel in Taiwan, Thailand and increasingly, Vietnam, said John Brown of Agoda, a subsidiary of Booking Holdings.
Shares of Chinese tech giants dropped earlier in November after draft rules that defined for the first time what constitutes anti-competitive behavior were released.
A series of high-profile defaults involving state-owned enterprises in China — normally a safe pick for investors — have jolted the credit market and rattled investors.
Risks for investors as well as developed markets are piling up with debt escalating during the coronavirus pandemic, according to a director at the Institute for International Finance.
The session in Asia follows a tepid finish overnight where U.S. stocks closed slightly higher as traders increased their exposure to major technology names.
Read the latest stock market news and analysis on Asia Pacific in regions from Japan, China, Singapore, Australia, to New Zealand. Find business; finance; economy, stocks, and global economy news on CNBC's Asia Pacific page.